261 related articles for article (PubMed ID: 32854437)
21. The Herpes Simplex Virus-1 genome contains multiple clusters of repeated G-quadruplex: Implications for the antiviral activity of a G-quadruplex ligand.
Artusi S; Nadai M; Perrone R; Biasolo MA; Palù G; Flamand L; Calistri A; Richter SN
Antiviral Res; 2015 Jun; 118():123-31. PubMed ID: 25843424
[TBL] [Abstract][Full Text] [Related]
22. A Parvovirus B19 synthetic genome: sequence features and functional competence.
Manaresi E; Conti I; Bua G; Bonvicini F; Gallinella G
Virology; 2017 Aug; 508():54-62. PubMed ID: 28500881
[TBL] [Abstract][Full Text] [Related]
23. The formation and modification of chromatin-like structure of human parvovirus B19 regulate viral genome replication and RNA processing.
Xu H; Hao S; Zhang J; Chen Z; Wang H; Guan W
Virus Res; 2017 Mar; 232():134-138. PubMed ID: 28263841
[TBL] [Abstract][Full Text] [Related]
24. G-Quadruplexes Formation at the Upstream Region of Replication Origin (OriL) of the Pseudorabies Virus: Implications for Antiviral Targets.
Zhu Y; Liu W; Zhang C
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835025
[TBL] [Abstract][Full Text] [Related]
25. Parvovirus B19 integration into human CD36+ erythroid progenitor cells.
Janovitz T; Wong S; Young NS; Oliveira T; Falck-Pedersen E
Virology; 2017 Nov; 511():40-48. PubMed ID: 28806616
[TBL] [Abstract][Full Text] [Related]
26. Role of erythropoietin receptor signaling in parvovirus B19 replication in human erythroid progenitor cells.
Chen AY; Guan W; Lou S; Liu Z; Kleiboeker S; Qiu J
J Virol; 2010 Dec; 84(23):12385-96. PubMed ID: 20861249
[TBL] [Abstract][Full Text] [Related]
27. High-Resolution Structure of the Nuclease Domain of the Human Parvovirus B19 Main Replication Protein NS1.
Sanchez JL; Ghadirian N; Horton NC
J Virol; 2022 May; 96(9):e0216421. PubMed ID: 35435730
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterization of two conserved G-quadruplex forming motifs in the Nipah virus genome and their interaction with G-quadruplex specific ligands.
Majee P; Kumar Mishra S; Pandya N; Shankar U; Pasadi S; Muniyappa K; Nayak D; Kumar A
Sci Rep; 2020 Jan; 10(1):1477. PubMed ID: 32001794
[TBL] [Abstract][Full Text] [Related]
29. Human Papillomavirus G-Rich Regions as Potential Antiviral Drug Targets.
Carvalho J; Lopes-Nunes J; Campello MPC; Paulo A; Milici J; Meyers C; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Nucleic Acid Ther; 2021 Feb; 31(1):68-81. PubMed ID: 33121376
[TBL] [Abstract][Full Text] [Related]
30. Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19.
Perrone R; Butovskaya E; Daelemans D; Palù G; Pannecouque C; Richter SN
J Antimicrob Chemother; 2014 Dec; 69(12):3248-58. PubMed ID: 25103489
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive Analysis of G-Quadruplexes in African Swine Fever Virus Genome Reveals Potential Antiviral Targets by G-Quadruplex Stabilizers.
Muturi E; Meng F; Liu H; Jiang M; Wei H; Yang H
Front Microbiol; 2021; 12():798431. PubMed ID: 34975822
[TBL] [Abstract][Full Text] [Related]
32. The genome of human parvovirus b19 can replicate in nonpermissive cells with the help of adenovirus genes and produces infectious virus.
Guan W; Wong S; Zhi N; Qiu J
J Virol; 2009 Sep; 83(18):9541-53. PubMed ID: 19587029
[TBL] [Abstract][Full Text] [Related]
33. Parvovirus B19 Replication and Expression in Differentiating Erythroid Progenitor Cells.
Bua G; Manaresi E; Bonvicini F; Gallinella G
PLoS One; 2016; 11(2):e0148547. PubMed ID: 26845771
[TBL] [Abstract][Full Text] [Related]
34. Telbivudine Reduces Parvovirus B19-Induced Apoptosis in Circulating Angiogenic Cells.
Zobel T; Bock CT; Kühl U; Rohde M; Lassner D; Schultheiss HP; Schmidt-Lucke C
Viruses; 2019 Mar; 11(3):. PubMed ID: 30845701
[No Abstract] [Full Text] [Related]
35. Different patterns of restriction to B19 parvovirus replication in human blast cell lines.
Gallinella G; Manaresi E; Zuffi E; Venturoli S; Bonsi L; Bagnara GP; Musiani M; Zerbini M
Virology; 2000 Dec; 278(2):361-7. PubMed ID: 11118359
[TBL] [Abstract][Full Text] [Related]
36. Human parvovirus B19 DNA replication induces a DNA damage response that is dispensable for cell cycle arrest at phase G2/M.
Lou S; Luo Y; Cheng F; Huang Q; Shen W; Kleiboeker S; Tisdale JF; Liu Z; Qiu J
J Virol; 2012 Oct; 86(19):10748-58. PubMed ID: 22837195
[TBL] [Abstract][Full Text] [Related]
37. The small 11 kDa nonstructural protein of human parvovirus B19 plays a key role in inducing apoptosis during B19 virus infection of primary erythroid progenitor cells.
Chen AY; Zhang EY; Guan W; Cheng F; Kleiboeker S; Yankee TM; Qiu J
Blood; 2010 Feb; 115(5):1070-80. PubMed ID: 19861680
[TBL] [Abstract][Full Text] [Related]
38. G-quadruplex binder pyridostatin as an effective multi-target ZIKV inhibitor.
Zou M; Li JY; Zhang MJ; Li JH; Huang JT; You PD; Liu SW; Zhou CQ
Int J Biol Macromol; 2021 Nov; 190():178-188. PubMed ID: 34461156
[TBL] [Abstract][Full Text] [Related]
39. Productive parvovirus B19 infection of primary human erythroid progenitor cells at hypoxia is regulated by STAT5A and MEK signaling but not HIFα.
Chen AY; Kleiboeker S; Qiu J
PLoS Pathog; 2011 Jun; 7(6):e1002088. PubMed ID: 21698228
[TBL] [Abstract][Full Text] [Related]
40. Update of the human parvovirus B19 biology.
Servant-Delmas A; Morinet F
Transfus Clin Biol; 2016 Feb; 23(1):5-12. PubMed ID: 26778837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]